QQQ   375.47 (+0.76%)
AAPL   148.76 (+1.51%)
MSFT   308.23 (+0.31%)
FB   339.99 (+1.39%)
GOOGL   2,864.74 (+0.32%)
TSLA   864.27 (-0.67%)
AMZN   3,444.15 (-0.08%)
NVDA   222.90 (+0.31%)
BABA   177.00 (+6.10%)
NIO   40.03 (+1.06%)
CGC   14.34 (+8.64%)
GE   104.73 (+0.59%)
AMD   116.33 (-0.09%)
MU   67.57 (+0.46%)
T   25.59 (+1.03%)
F   15.42 (-0.90%)
ACB   7.45 (+7.66%)
DIS   171.18 (+0.02%)
PFE   42.09 (+1.86%)
BA   215.97 (-0.47%)
AMC   40.80 (-5.18%)
QQQ   375.47 (+0.76%)
AAPL   148.76 (+1.51%)
MSFT   308.23 (+0.31%)
FB   339.99 (+1.39%)
GOOGL   2,864.74 (+0.32%)
TSLA   864.27 (-0.67%)
AMZN   3,444.15 (-0.08%)
NVDA   222.90 (+0.31%)
BABA   177.00 (+6.10%)
NIO   40.03 (+1.06%)
CGC   14.34 (+8.64%)
GE   104.73 (+0.59%)
AMD   116.33 (-0.09%)
MU   67.57 (+0.46%)
T   25.59 (+1.03%)
F   15.42 (-0.90%)
ACB   7.45 (+7.66%)
DIS   171.18 (+0.02%)
PFE   42.09 (+1.86%)
BA   215.97 (-0.47%)
AMC   40.80 (-5.18%)
QQQ   375.47 (+0.76%)
AAPL   148.76 (+1.51%)
MSFT   308.23 (+0.31%)
FB   339.99 (+1.39%)
GOOGL   2,864.74 (+0.32%)
TSLA   864.27 (-0.67%)
AMZN   3,444.15 (-0.08%)
NVDA   222.90 (+0.31%)
BABA   177.00 (+6.10%)
NIO   40.03 (+1.06%)
CGC   14.34 (+8.64%)
GE   104.73 (+0.59%)
AMD   116.33 (-0.09%)
MU   67.57 (+0.46%)
T   25.59 (+1.03%)
F   15.42 (-0.90%)
ACB   7.45 (+7.66%)
DIS   171.18 (+0.02%)
PFE   42.09 (+1.86%)
BA   215.97 (-0.47%)
AMC   40.80 (-5.18%)
QQQ   375.47 (+0.76%)
AAPL   148.76 (+1.51%)
MSFT   308.23 (+0.31%)
FB   339.99 (+1.39%)
GOOGL   2,864.74 (+0.32%)
TSLA   864.27 (-0.67%)
AMZN   3,444.15 (-0.08%)
NVDA   222.90 (+0.31%)
BABA   177.00 (+6.10%)
NIO   40.03 (+1.06%)
CGC   14.34 (+8.64%)
GE   104.73 (+0.59%)
AMD   116.33 (-0.09%)
MU   67.57 (+0.46%)
T   25.59 (+1.03%)
F   15.42 (-0.90%)
ACB   7.45 (+7.66%)
DIS   171.18 (+0.02%)
PFE   42.09 (+1.86%)
BA   215.97 (-0.47%)
AMC   40.80 (-5.18%)
NASDAQ:THMO

ThermoGenesis Stock Forecast, Price & News

$1.81
+0.02 (+1.12 %)
(As of 10/19/2021 12:00 AM ET)
Add
Compare
Today's Range
$1.77
$1.81
50-Day Range
$1.79
$2.45
52-Week Range
$1.73
$4.45
Volume27,257 shs
Average Volume613,322 shs
Market Capitalization$21.56 million
P/E RatioN/A
Dividend YieldN/A
Beta3.23
30 days | 90 days | 365 days | Advanced Chart
Receive THMO News and Ratings via Email

Sign-up to receive the latest news and ratings for ThermoGenesis and its competitors with MarketBeat's FREE daily newsletter.


ThermoGenesis logo

About ThermoGenesis

ThermoGenesis Holdings, Inc. engages in the research, development, commercialization, and marketing of automated cell processing technologies for the cell and gene therapy field. It operates through the Device and Clinical Development segment. The Device segment includes the development and commercialization of automated technologies for cell-based therapeutics and bioprocessing. The Clinical Development segment utilizes autologous stem cell-based therpeutics. The company was founded by Philip H. Coelho in 1986 and is headquartered in Rancho Cordova, CA.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Laboratory apparatus & furniture
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:THMO
Employees
41
Year Founded
N/A

Sales & Book Value

Annual Sales
$9.74 million
Book Value
$0.66 per share

Profitability

Net Income
$-16.35 million
Net Margins
-152.92%

Debt

Price-To-Earnings

Miscellaneous

Market Cap
$21.56 million
Next Earnings Date
11/11/2021 (Estimated)
Optionable
Not Optionable

MarketRank

Overall MarketRank

1.93 out of 5 stars

Medical Sector

666th out of 1,361 stocks

Laboratory Apparatus & Furniture Industry

1st out of 3 stocks

Analyst Opinion: 3.5Community Rank: 3.9Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -












ThermoGenesis (NASDAQ:THMO) Frequently Asked Questions

Is ThermoGenesis a buy right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ThermoGenesis in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" ThermoGenesis stock.
View analyst ratings for ThermoGenesis
or view top-rated stocks.

What stocks does MarketBeat like better than ThermoGenesis?

Wall Street analysts have given ThermoGenesis a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but ThermoGenesis wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting ThermoGenesis?

ThermoGenesis saw a drop in short interest in the month of September. As of September 30th, there was short interest totaling 236,100 shares, a drop of 23.8% from the September 15th total of 309,900 shares. Based on an average daily volume of 213,500 shares, the days-to-cover ratio is presently 1.1 days. Currently, 2.5% of the shares of the stock are sold short.
View ThermoGenesis' Short Interest
.

When is ThermoGenesis' next earnings date?

ThermoGenesis is scheduled to release its next quarterly earnings announcement on Thursday, November 11th 2021.
View our earnings forecast for ThermoGenesis
.

How were ThermoGenesis' earnings last quarter?

ThermoGenesis Holdings, Inc. (NASDAQ:THMO) released its quarterly earnings data on Thursday, August, 12th. The company reported ($0.38) EPS for the quarter, missing the Zacks' consensus estimate of ($0.18) by $0.20. The firm earned $2.20 million during the quarter, compared to the consensus estimate of $1.99 million. ThermoGenesis had a negative trailing twelve-month return on equity of 178.57% and a negative net margin of 152.92%.
View ThermoGenesis' earnings history
.

How has ThermoGenesis' stock price been impacted by Coronavirus?

ThermoGenesis' stock was trading at $3.10 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, THMO shares have decreased by 41.6% and is now trading at $1.81.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for THMO?

1 analysts have issued 1 year price objectives for ThermoGenesis' shares. Their forecasts range from $6.00 to $6.00. On average, they expect ThermoGenesis' stock price to reach $6.00 in the next year. This suggests a possible upside of 231.5% from the stock's current price.
View analysts' price targets for ThermoGenesis
or view top-rated stocks among Wall Street analysts.

Who are ThermoGenesis' key executives?

ThermoGenesis' management team includes the following people:
  • Xiao Chun Xu, Chairman, President & Chief Executive Officer
  • Hai Hong Zhu, Chief Operating Officer
  • Jeffery Cauble, Secretary & Chief Financial Officer
  • Mindy Wilke-Douglas, Vice President-Operations
  • Wendy Samford, Investor Relations Contact

What other stocks do shareholders of ThermoGenesis own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ThermoGenesis investors own include FuelCell Energy (FCEL), Inovio Pharmaceuticals (INO), Co-Diagnostics (CODX), NVIDIA (NVDA), OPKO Health (OPK), Advanced Micro Devices (AMD), Dynavax Technologies (DVAX), Gilead Sciences (GILD), Pfizer (PFE) and AbbVie (ABBV).

What is ThermoGenesis' stock symbol?

ThermoGenesis trades on the NASDAQ under the ticker symbol "THMO."

How do I buy shares of ThermoGenesis?

Shares of THMO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ThermoGenesis' stock price today?

One share of THMO stock can currently be purchased for approximately $1.81.

How much money does ThermoGenesis make?

ThermoGenesis has a market capitalization of $21.56 million and generates $9.74 million in revenue each year. The company earns $-16.35 million in net income (profit) each year or ($2.60) on an earnings per share basis.

How many employees does ThermoGenesis have?

ThermoGenesis employs 41 workers across the globe.

What is ThermoGenesis' official website?

The official website for ThermoGenesis is www.thermogenesis.com.

Where are ThermoGenesis' headquarters?

ThermoGenesis is headquartered at 2711 CITRUS ROAD, RANCHO CORDOVA CA, 95742.

How can I contact ThermoGenesis?

ThermoGenesis' mailing address is 2711 CITRUS ROAD, RANCHO CORDOVA CA, 95742. The company can be reached via phone at (916) 858-5100 or via email at [email protected].


This page was last updated on 10/19/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.